Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Immunity & Ageing : I & A
|
May 14, 2014
LATEX sensitization in elderly: allergological study and diagnostic protocol
Teresa Grieco, Valentina Faina, Laura Dies, et al.
Immunotherapy
|
September 7, 2020
Potential clinical and serological predictors of chronic spontaneous urticaria relapse in patients under omalizumab treatment
Teresa Grieco, Laura Dies, Alvise Sernicola, et al.
Clinical and Molecular Allergy : CMA
|
March 27, 2019
Rapid clinical improvement of atopic dermatitis in an Omalizumab treated patient
Susanna Bormioli, Andrea Matucci, Laura Dies, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 17, 2020
Desensitization modulates humoral and cellular immune response to infliximab in a patient with an immediate hypersensitivity reaction
Alessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
Scientific Reports
|
June 16, 2021
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis
Alessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
European Journal of Gastroenterology & Hepatology
|
April 13, 2018
Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases
Michele Spinicci, Giacomo Emmi, Laura Dies, et al.
Allergy, Asthma & Immunology Research
|
July 9, 2020
Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
Alessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
Frontiers in Immunology
|
January 29, 2019
T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis
Sara Pratesi, Francesca Nencini, Francesca Grosso, et al.
Dermatologic Therapy
|
December 22, 2019
A severe adverse reaction to omalizumab therapy in chronic spontaneous urticaria
Laura Dies, Alvise Sernicola, Francesca Magri, et al.
Frontiers in Immunology
|
June 14, 2018
Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich's Syndrome
Andrea Matucci, Francesco Liotta, Emanuele Vivarelli, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Immunity & Ageing : I & A
|
May 14, 2014
LATEX sensitization in elderly: allergological study and diagnostic protocol
Teresa Grieco, Valentina Faina, Laura Dies, et al.
Immunotherapy
|
September 7, 2020
Potential clinical and serological predictors of chronic spontaneous urticaria relapse in patients under omalizumab treatment
Teresa Grieco, Laura Dies, Alvise Sernicola, et al.
Clinical and Molecular Allergy : CMA
|
March 27, 2019
Rapid clinical improvement of atopic dermatitis in an Omalizumab treated patient
Susanna Bormioli, Andrea Matucci, Laura Dies, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 17, 2020
Desensitization modulates humoral and cellular immune response to infliximab in a patient with an immediate hypersensitivity reaction
Alessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
Scientific Reports
|
June 16, 2021
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis
Alessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
European Journal of Gastroenterology & Hepatology
|
April 13, 2018
Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases
Michele Spinicci, Giacomo Emmi, Laura Dies, et al.
Allergy, Asthma & Immunology Research
|
July 9, 2020
Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
Alessandra Vultaggio, Francesca Nencini, Susanna Bormioli, et al.
Frontiers in Immunology
|
January 29, 2019
T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis
Sara Pratesi, Francesca Nencini, Francesca Grosso, et al.
Dermatologic Therapy
|
December 22, 2019
A severe adverse reaction to omalizumab therapy in chronic spontaneous urticaria
Laura Dies, Alvise Sernicola, Francesca Magri, et al.
Frontiers in Immunology
|
June 14, 2018
Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich's Syndrome
Andrea Matucci, Francesco Liotta, Emanuele Vivarelli, et al.
Page
of 1